Cost‐effectiveness analysis of primary treatments for localised prostate cancer: A population‐based Markov analysis using real‐world evidence is a research paper published in European Journal of Cancer Care (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5RC1CA146596‐02
NIH HHS
Grant: 5RC1CA146596-02
FWCI
0.41
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords